Healthbeat on MSN1d
Covid cases in Georgia could soon see an uptick, CDC data showWhile flu and RSV hospitalizations continue to drop in Georgia, wastewater data indicate that Covid cases could soon be on ...
9d
News-Medical.Net on MSNRSV hospitalization rates rise with age and chronic conditions in older adultsAmong older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively with age and is more likely among people with other health issues and who ...
Uruguay's Public Health Ministry (MSP) launched its 2025 vaccination campaign, focusing on influenza, measles, and ...
It reached the highest rate among those aged 85─94, with more than 200 RSV hospitalisations per 100,000 people in this group. This increased risk might be explained by the gradual decline of the ...
"They came out with a vaccine for babies six months and younger, so that can definitely help prevent severe infection and hospitalizations from RSV," Rosner explained. "Also pregnant mothers can ...
Among the viruses circulating most are COVID-19, flu and RSV. So far this season, the CDC estimates, there have been at least 24 million flu illnesses, 310,000 hospitalizations and 13,000 deaths ...
It's the season for colds and flu, but this year is shaping up to be one of the worst flu seasons many doctors have seen in more than a decade. "We're having a lot of kids coming in very sick ...
But with COVID-19, the flu, respiratory syncytial virus, or RSV, and just the common cold all floating around and all sharing several similar symptoms, how are you supposed to know what you might ...
Americans are weathering the worst flu season in years, as a number of other respiratory illnesses circulate too, such as COVID-19, RSV and the common cold. A telltale sign you’re getting sick ...
Respiratory syncytial virus (RSV) is a cold-like illness that can be dangerous for infants, especially those born during the respiratory season. We finally have a tool to protect them, yet ...
The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study. The phase 3 randomized controlled ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results